Armando Anido's Insider Trades & SAST Disclosures
Armando Anido's most recent trade in Scynexis Inc was a trade of 23,000 Stock Option done . Disclosure was reported to the exchange on June 20, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Armando Anido.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Scynexis Inc | Armando Anido | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 23,000 | 23,000 | - | - | Stock Option | |
| Scynexis Inc | Armando Anido | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 23,000 | 48,000 (0%) | 0% | 0 | Common Stock | |
| Scynexis Inc | Armando Anido | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 10,000 | 25,000 (0%) | 0% | 0 | Common Stock | |
| Scynexis Inc | Armando Anido | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 10,000 | 10,000 | - | - | Stock Option | |
| Zynerba Pharmaceuticals Inc | Armando Anido | Director, Chairman & Chief Exec. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2023 | 45,406 | 902,352 (3%) | 0% | - | Common Stock | |
| Zynerba Pharmaceuticals Inc | Armando Anido | Director, Chairman & Chief Exec. Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.60 per share. | 07 Feb 2023 | 12,547 | 889,805 (3%) | 0% | 0.6 | 7,484 | Common Stock |
| Zynerba Pharmaceuticals Inc | Armando Anido | Director, Chairman & Chief Exec. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 42,437 | 868,672 (3%) | 0% | - | Common Stock | |
| Zynerba Pharmaceuticals Inc | Armando Anido | Director, Chairman & Chief Exec. Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.60 per share. | 31 Jan 2023 | 11,726 | 856,946 (3%) | 0% | 0.6 | 6,979 | Common Stock |
| Zynerba Pharmaceuticals Inc | Armando Anido | Director, Chairman & Chief Exec. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2023 | 250,000 | 826,235 (3%) | 1% | 0 | Common Stock | |
| Zynerba Pharmaceuticals Inc | Armando Anido | Director, Chairman & Chief Exec. Officer | Sale of securities on an exchange or to another person at price $ 0.60 per share. | 23 Jan 2023 | 35,453 | 576,235 (2%) | 0% | 0.6 | 21,194 | Common Stock |
| Zynerba Pharmaceuticals Inc | Armando Anido | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jul 2022 | 43,164 | 623,587 (2%) | 0% | - | Common Stock | |
| Zynerba Pharmaceuticals Inc | Armando Anido | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 1.10 per share. | 18 Jul 2022 | 11,899 | 611,688 (2%) | 0% | 1.1 | 13,089 | Common Stock |
| Scynexis Inc | Armando Anido | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Scynexis Inc | Armando Anido | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 10,000 | 15,000 (0%) | 0% | 0 | Common Stock | |
| Zynerba Pharmaceuticals Inc | Armando Anido | Director, Chairman & Chief Exec. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2022 | 190,000 | 190,000 | - | - | Stock Option (right to buy) | |
| Zynerba Pharmaceuticals Inc | Armando Anido | Director, Chairman & Chief Exec. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2022 | 120,000 | 580,423 (2%) | 0% | 0 | Common Stock | |
| Scynexis Inc | Armando Anido | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Zynerba Pharmaceuticals Inc | Armando Anido | Director, Chairman & Chief Exec. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2021 | 161,867 | 161,867 | - | - | Stock Option (right to buy) | |
| Zynerba Pharmaceuticals Inc | Armando Anido | Director, Chairman & Chief Exec. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2021 | 107,911 | 460,423 (1%) | 0% | 0 | Common Stock | |
| Scynexis Inc | Armando Anido | Director | Purchase of securities on an exchange or from another person at price $ 6.25 per share. | 21 Dec 2020 | 5,000 | 5,000 (0%) | 0% | 6.3 | 31,250 | Common Stock |
| Scynexis Inc | Armando Anido | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2020 | 2,500 | 2,500 | - | - | Common Stock Warrant | |
| Scynexis Inc | Armando Anido | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2020 | 2,500 | 2,500 | - | - | Common Stock Warrant | |
| Scynexis Inc | Armando Anido | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jul 2020 | 45,000 | 45,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges